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Background. We sought to evaluate and better provide itinerary-specific care to pre-
counseled travelers by surveying a community population to assess diseases occurring 
during travel abroad. An additional quality improvement initiative was to expand our 
post-travel survey to be a more valuable tool in gathering high-quality quantitative data. 
Methods. From de-identified data collected via post-travel surveys, we identified a cohort 
of 525 patients for a retrospective observational analysis. We analyzed illness 
encountered while abroad, medication use, and whether a physician was consulted. We 
also examined itinerary variables, including continents and countries visited. 
Results. Of 525 post-travel surveys collected, the majority of respondents traveled to Asia 
(31%), or Africa (30%). The mean number of travel days was 21.3 (median, 14). 
Univariate analysis demonstrated a statistically significant increase of risk for general 
illness when comparing travel duration of less than 14 days to greater than 14 days 
(11.3% vs. 27.7%, p<0.001). Duration of travel was also significant with regard to 
development of traveler’s diarrhea (TD) (p=0.0015). Destination of travel and 
development of traveler’s diarrhea trended toward significance. Serious illness requiring 
a physician visit was infrequent, as were vaccine-related complications. 
Conclusion. Despite pre-travel counseling, traveler’s diarrhea was the most common 
illness in our cohort; expanded prevention strategies will be necessary to lower the 
impact that diarrheal illness has on generally healthy travelers. Overall rates of illness did 
not vary by destination; however, there was a strong association between duration of 
travel duration and likelihood of illness. To further identify specific variables contributing 
3 
 
to travel-related disease, including patient co-morbidities, reason for travel, and 
accommodations, the post-travel survey has been modified and expanded. A limitation of 
this study was the low survey response rate (18%); to improve the return rate, we plan to 







In 2011, as reported by the World Tourism Organization, 980 million travelers crossed an 
international border. This number contrasts with 675 million international departures of 
only 10 years ago.
1
 Due to this explosive increase in international travel, the practice of 
travel medicine continues to grow. Currently, there are 625 travel clinics providing pre-
travel medical care and counseling in the United States, as compiled by the International 
Society of Travel Medicine.
2
 As recently reported by the Global TravEpiNet, up to 59% 
of selected travelers have an underlying medical condition and many 
immunocompromised patients are traveling to developing countries.
3
 Previous studies 





We set out to perform a retrospective, observational analysis of three years of 
post-travel survey data to determine associations between travel-related illness and 
unique features of the travel itinerary, along with other specific demographic variables. 
We hypothesized that we would be better able to define high-risk travel destinations, 
determine predictors, and develop a more meaningful survey tool to monitor the quality 
of itinerary-specific care delivered in the clinic.  
 
Methods 
Our travel medicine clinic is best described as a medium-size practice 
incorporated into a large Infectious Diseases practice. We are located in the third largest 
catchment in Pennsylvania. For 14 years, we have been collecting post-travel survey data 
for purposes of quality control and process improvement. Each year, we see more than 
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500 individuals, including those travelling in large group trips, for pre-travel medical care 
and counseling. The number of visits has been increasing by about 10% per year for the 
past three years.  
The travel medicine database and survey tool used in the study were approved by 
our network’s institutional review board. We mailed one-page surveys (Appendix 1) to 
all previously counseled travelers within one month after their planned departure date, 
with instructions to complete and mail back the surveys upon their return. No repeat 
mailings or other reminders were sent. Travelers were queried if they became ill, what 
symptoms they experienced, and if they sought medical help (arbitrarily defined as a 
serious illness). We also obtained information about their diagnoses and the medications 
prescribed. If travelers developed diarrhea, they were asked to record the type of 
medication that they used for treatment. 
 Data gathered from all surveys returned over a 14-year period were entered into a 
de-identified database, from which we identified a retrospective cohort of 525 individuals 
who were seen in the travel clinic from May 2007 through December 2010. From this 
cohort, simple percentages were calculated for rates of illness by category 
(gastrointestinal, respiratory, etc) and also rates of illness based on continent destination. 
We then compared the travel-specific itinerary and demographics, including age of 
traveler, lag time from pre-travel visit to travel, the destination (by continent), and 
duration of travel related to the likelihood of illness, travel-related gastrointestinal illness 
(usually diarrhea), and the likelihood of seeing a medical care provider. Statistical 
analysis included Chi-square tests for categorical variables and independent t-tests for 
continuous variables. Each variable distribution was tested for normality. If assumptions 
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for the parametric tests were not met, non-parametric equivalents were employed, 
including Wilcoxin Rank Sum and Fischer’s Exact Tests. 
 We examined the data from a quality improvement perspective: deficiencies that 
were noted in the data tabulation were identified and, from these, a repeat survey tool was 
created. We plan to test this new, improved survey tool in the future by combining the 
information in the current database with an expanded version. 
 
Results 
Data collection demonstrated an 18% return rate of the survey over the collection 
period. Of travelers who returned the survey, 31% had traveled to Asia, 30% went to 
Africa, 20% to South America, and 14% to Central America. Of all travelers, 3.6% went 
to high-income destinations in Europe and Australia and 1.4% traveled to multiple 
continents.  
 Illness was reported in 104 (19.8%) of the cohort. The most common illnesses 
were gastrointestinal related, reported by 75 (14.3%) of all travelers (Figure 1).  
Gastrointestinal illness accounted for 76% of all reported illness. The majority of 
the gastrointestinal cases were diarrheal disease, although nausea and vomiting were also 
commonly reported. Respiratory illness, accounting for 14% of all illness reported, was 
the next most common, occurring in 17 (3.4%) of all respondents. Systemic illness, skin 
disorders, and “other” illness made up the remainder of the reported illness (Figure 1). Of 




 The destinations with the highest risk of reported illness were South 
America (27.3% of all respondents); Asia, including India, (21.5%); and Africa with 
17.4% (Table 1). There was no difference in the rates of self-reported illness among 
travelers to Africa, Asia, South America, and Central America (p=0.37). Serious illness 
(defined as illness requiring medical attention) occurred in 8.1% of travelers to South 
America, 5.7% of travelers to Asia, 5.2% of travelers to Central America and 4.3% of 
travelers to Africa. Both general illness and serious illness were rarely reported among 
travelers to developed countries in Europe and Australia.  
Gastrointestinal illness, particularly traveler’s diarrhea, was the most common 
affliction. Despite receiving pre-travel counseling, a significant portion of travelers to 
developing regions reported diarrhea. Rates exceeded 25% in Africa and South America: 
26.9% and 28.3%, respectively (Table 1). Rates of traveler’s diarrhea were slightly lower 
in Asia at 20.2%. The differences in traveler’s diarrhea rates between these continents 
were not significant (p=0.30). 
 The duration of travel was found to be a significant risk factor for acquiring 
illness abroad. We stratified our responses into quartiles regarding durations of travel 
(Figure 2). Of travelers going abroad for less than two weeks, only 11.6% (27/232) 
developed any degree of illness, whereas 40.0% (18/45) of travelers staying abroad 
longer than 6 weeks reported illness (p=<0.001, for travel >6wks). The prevalence of 
traveler’s diarrhea was also highly associated with duration of travel: 19.6% of short-term 
(2 weeks or less) travelers developed diarrhea, versus 29.8% of longer-term (greater than 
2 weeks) travelers (p=0.024).  
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 We found no difference in the overall rates of illness for vaccinated travelers 
versus non-vaccinated travelers, although 91% of travelers received pre-travel 
vaccination. The study was not powered or designed to assess vaccine efficacy in the 
prevention of overall illness.  
 The travel cohort was divided into quartiles based on the interval from their travel 
visit until their departure (1-2 wks, 2-4 wks, 4-6 wks, and >6wks). There was no 
statistical difference noted between the quartiles regarding the lead time from clinic visit 
to departure and the relative rates of illness.  
 Qualitative response data, such as the usefulness of the pre-travel visit and 
counseling was also evaluated. Respondents were asked to rate the quality of pre-travel 
advice given to them on a 4-point scale from “none of it helpful” (=1) to “all of it 
helpful” (=4); of the responders, 92.2% found “most” or “all” of the travel advice to be 
helpful.   
 
Discussion 
 Results of our retrospective survey analysis reveal that high rates of self-reported 
illness in returning travelers remain a significant issue. The overall rate of illness in 
travelers to developing countries destinations averaged 20% among our convenience 
cohort, regardless of the continent visited. A comprehensive review by Steffen
5
 of prior 
studies reported a historic rate of up to 77% for general illness occurring in travelers to 
developing countries. Although illness rates in our study were lower than in the Steffen 
review, and lower than in several other cohort studies,
6-9
 they still are relatively high 
considering that all of these individuals sought pre-travel counseling. In contrast to 
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previously published survey studies, we did not find statistically different illness rates 
among our travelers going to Asia, Africa, Central America, and South America.
6,7
  
The most striking finding was a strong association between the duration of travel 
and the incidence of general illness and severe illness as defined above. Long-term 
travelers (in our study we defined long term as greater than 4 weeks) had more than twice 
the rates of illness and traveler’s diarrhea than did our short-term travelers (Figure 2). 
These illness rates are comparable to an earlier travel survey study of Swedish travelers, 
which showed a significant correlation (OR=3.2) between illness and travel duration of 
greater than four weeks.
9
 Similarly, a study by Winer and Alkan also noted a significant 
effect of trip duration on likelihood of illness, although the mean duration of travel in 
their population was much longer at 14.7 weeks.
10
 In addition, DR Hill’s study on health 
problems in American travelers demonstrated a 3 to 4% increased risk of developing 
illness with each additional day of travel.
7
  
It is interesting to note that, in our study, rates of diarrhea exceed the rates of 
reported illness in some destinations. Our observation was that travelers often reported 
diarrhea, but did not always consider it to be an “illness.”  
Being that gastrointestinal illness accounts for the majority (76%) of all illness 
reported in our study, it is clear that emphasizing the heightened risk of illness associated 
with long travel may be necessary to counter the increased morbidity rates. The relatively 
high rates of traveler’s diarrhea are somewhat disappointing given our emphasis on 
prevention and management of this ailment at the pre-travel visit. Fortunately, the 
availability of standby antibiotic treatment may have helped to minimize the impact of 
this illness on our travel group. An alternate option that might better manage these high 
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diarrheal rates is the use of prophylactic non-absorbable antibiotics, as was shown 
effective in a randomized, double-blind study of US students travelling to Mexico.
11
 
Interestingly, the interval from pre-travel assessment to trip departure was not 
associated with the rates of illness or traveler’s diarrhea, despite strong recommendations 
to be seen at least 4-6 weeks prior to departure. It should be noted that this study was not 
powered to determine if too short of an interval prior to departure would result in 
increased illness rates, particularly with regard to vaccine preventable diseases. It is 
reassuring to know that even “late” pre-travel assessments may be of benefit to the 
traveler.  
Almost 30% of all ill travelers in this cohort did seek medical attention—a finding 
that did not vary by destination continent. This number is much higher than those 




 at rates of about 10% and 16%, respectively. 
Our rate was closer to that of a large cohort study of Swiss travelers, which demonstrated 
relatively high rates of physician consultation and incapacitation among those who were 
ill.
8
 Despite our designation of serious illness, however, none of our travelers required 
prolonged hospitalization and none died. As was reported in a recent cohort study of 
French travelers to Senegal, some more serious illnesses, often with longer incubation 
periods, may not be captured by the single-center cohort study design.
12
   
Our study results were comparable to those in a study Caumes et al, also 
conducted in the community setting, which revealed similar illness distribution patterns.
13
 
Single-center cohort studies such as ours are among the most common type of travel 
medicine research study design. One advantage of this study approach is the ability to 
capture pre-travel demographic and itinerary data, which can then be compared to post-
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travel illness rates to determine relative disease risks for each destination. However, 
single-center cohort studies are often limited to reporting their results by syndromic 
diagnoses, rather than by specific disease entities, due to limited numbers of travelers.
14
  
Other epidemiologic approaches in travel medicine research, such as large 
surveillance network studies, offer the potential for more specific disease diagnoses. In 
addition, larger surveillance studies allow for other types of data analysis such as 
proportionate morbidities and assessment of disease trends over time.
14
 A drawback of 
these surveillance studies, however, is the inability to calculate specific disease rates for a 
defined geographic region.  
Limitations of our study include the retrospective aspect of this survey tool, 
potentially leading to recall bias. As a counteractive measure, we mailed surveys during 
the month of our patients’ travel; in many cases the surveys had already been delivered 
by the time the travelers returned home. Another limitation was the subjective nature of 
the survey tool, which made it difficult to categorize illness into the discrete disease 
entities. In addition, the low overall survey response may preclude one from generalizing 
our results to a larger travel population. In the cohort study of American travelers by Hill, 
follow-up phone interviews were conducted with those who reported illness as well as 
with survey non-responders.
7
 This strategy might be helpful to maximize survey response 
rates and also to potentially minimize the effects of recall bias.  
As our initial focus was on the most common travel ailments for which our 
patients were pre-counseled, the original survey did not include questions regarding type 
of travel (e.g. business or tourism), nor did we ask about pre-existing conditions. Based 
12 
 
on the limitations of our cohort study, implementation of a modified survey (Appendix 2) 
should better capture post-travel illness data.  
 
Conclusion 
Our survey tool has demonstrated value as a novel method for quality 
improvement in this travel medicine clinic, and has captured travel-related variables 
useful for defining predictors of acquiring illness in travel abroad. Future directions for 
our clinic will incorporate the development of additional survey modalities, including a 
web-based survey to improve response rates and adoption of the method used by Hill in 
delivering surveys prior to departure
7
 so that participants can log their illnesses in “real 
time” while traveling. We recommend that other clinics use a similar survey process to 
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Table 1   Traveler Characteristics   








Asia 117 25 (21%) 25 (21%) 
S. America 99 27 (27%) 28 (28%) 
Africa 161 28 (17%) 43 (27%) 
Europe 13 0 (0%) 0 (0%) 
C. America 74 12 (16%) 13 (18%) 
Australia 5 0 (0%) 0 (0%) 
India 46 10 (22%) 8 (17%) 
Multiple Continents 10 2 (20%) 3 (30%) 
Total 525 104 (20%) 120 (23%) 
    
*Some travelers did not report TD as "illness"   
16 
 




Thank you for choosing our travel clinic for your pre-travel consultation and immunizations.  We greatly 
appreciate your time and energy in completing this questionnaire. Information provided below will help us 
improve all aspects of our travel medicine service. Answers to the following questions will be used in 
building a research database to optimize travel disease prevention. Information provided will be kept 
confidential.  Please print clearly and legibly. 
 
General Information: 
1. Which country did you travel to? _______________________________      
2.  How long was your total trip? _______________ 
3.  How many individuals did you travel with? ______________ 
Illness: 
1.  Did you become ill during your trip?   Yes       No 
2.  What were the main symptoms? ___________________________________ 
3.  Did you seek help from a local physician?     Yes       No 
      a.  What diagnosis were you given? ________________________________ 
      b.  Were you given any medications?  Yes ______________________   No   
Diarrhea: 
1.  Did you take any preventative medication for “Traveler’s Diarrhea” If 
yes, what did you take?    Yes  ________________________________    No 
2.  Did you develop diarrhea during your trip?    Yes            No 
3.  What did you take for it? _____________________________ 
4.  How long did it last?     1-2 days      3-4 days      5 + days 
Insects & Mosquitoes: 
1.  Did you notice a lot of mosquitoes?    Yes             No 
2.  Where were they the most numerous? _________________ 
3.  Did you get a lot of bites?     Yes              No 
4.  Which repellent did you use (brand name)? ______________________ 
5.  Do you think it worked well?    Yes              No 
Vaccines: 
1.  Did you receive vaccines for this trip?     Yes            No 
2.  Did you have any problems with the vaccines?     Yes                No 
 Which vaccine(s)?  _________________________________ 
Relevance of Advice: 
1.  Did the advice you received seem appropriate to your needs? 
      All of it                   Most all of it              Some of it               None  
2.  Were any items not covered that you think should have been?  
     __________________________________________________________________ 
17 
 
3.  Any other comments or suggestions?  
__________________________________________________________________
__________________________________________________________________ 
Once again we thank you very much for your time and effort with these questions!  Please return your post 
travel survey in the envelope provided.                                                                                       
 
Name: ______________________________ Date of trip: _____________ 




Appendix 2   Updated Survey 
 
Travel Medicine Clinic Post-travel Survey 
 
Name (optional) :__________________________ Age:_________ Sex:_______ 
 
1. Which continent(s) did you visit during your travel? 
 Asia          South America           Africa           Europe                                                      
 North and Central America         Australia         India  
Which specific countries did you visit?  _________________________________ 
2.  How long was your total trip (days)? ______________ 
3.  Primary reason for travel:   Tourism         Business         Volunteer/Mission        
       Visit Relatives/Friends         Adoption         Other_____________________ 
4.  Did you become ill during your trip?   Yes         No 
 If Yes, what were the primary Symptoms?  
   Gastrointestinal (Nausea, Vomiting, Abdominal Pain, Diarrhea) 
   Respiratory (Cough, Congestion, Cold, Pneumonia, Asthma) 
   Cutaneous (Rashes) 
   Systemic (Fevers, Chills, Headache, etc.) Please Specify____________ 
5.  Did you seek help from a local physician or hospital?  Yes         No 
 If Yes, what diagnosis were you given? ________________________________ 
 Did you receive any medication?  Yes          No 
  If Yes, please specify: ________________________________________ 
6.  Did you take any Antibiotics to treat Traveler’s Diarrhea (TD)? 
   Yes         No 
 If yes, which one(s)?   Cipro (Ciprofloxacin)        Zithromax (Azithromycin) 
     Xifaxan (Rifaximin)         Other: _________________ 
7.  Did you develop TD during your trip (3 or more unformed stools in a period of 24 
hours or any unformed stools with Nausea, Abdominal Pain, Fever, Cramps)?   
 Yes         No 
 If yes, how long did it last?    1-2 Days         3-4 Days        5 or more Days 
8.  Which vaccines (if any) did you receive for this trip? 
 Yellow Fever  Hepatitis A   Hepatitis B   Tetanus-Diptheria 
 Typhoid  Polio  Meningococcus   Other: ____________________ 
9. Did you have any side effects from the vaccinations?  Yes         No 
 If yes, please explain side effects: ____________________________________ 
10.  Do you have any of the following medical conditions?   Diabetes       COPD 
 Coronary Disease/Congestive Heart Failure     Cancer 
11.  On a scale of 1-10, please rate your satisfaction with your travel visit with our travel 
medicine clinic (1 = Extremely Unsatisfied; 10 = Extremely Satisfied): _______ 




Figure legends  
 
Figure 1: Classification of Illness 
Figure 2: Percentage of Travelers Developing Traveler’s Diarrhea by Duration of Travel 
    (n = total travelers per time interval) 
Figure 1 
Figure 2 
